Current Drug Therapy
Recombinant human PTH 1-34 (Forteo): An anabolic drug for osteoporosis
Chad Deal, MD and James Gideon, MD, PhD
Cleveland Clinic Journal of Medicine July 2003, 70 (7) 585-601;
Chad Deal
Head, Center for Osteoporosis and Metabolic Bone Disease, Department of Rheumatic and Immunologic Disease, The Cleveland Clinic
James Gideon
Blanchard Valley Medical Associates, Findlay, Ohio

Article Information
vol. 70 no. 7 585-601
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online July 1, 2003.
Copyright & Usage
Copyright © 2003 The Cleveland Clinic Foundation. All Rights Reserved.
Cited By...
In this issue
Cleveland Clinic Journal of Medicine
Vol. 70, Issue 7
1 Jul 2003
Recombinant human PTH 1-34 (Forteo): An anabolic drug for osteoporosis
Chad Deal, James Gideon
Cleveland Clinic Journal of Medicine Jul 2003, 70 (7) 585-601;
Jump to section
Related Articles
- No related articles found.